Filing Details

Accession Number:
0001140361-12-027463
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-25 16:54:53
Reporting Period:
2012-05-23
Filing Date:
2012-05-25
Accepted Time:
2012-05-25 16:54:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
350907 Thoratec Corp THOR Electromedical & Electrotherapeutic Apparatus (3845) 942340464
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1217439 W Elisha Finney 6035 Stoneridge Drive
Pleasanton CA 94588
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-23 5,579 $0.00 25,171 No 4 A Direct
Common Stock Disposition 2012-05-25 637 $31.47 24,534 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect By Separate Property Trust
Footnotes
  1. Represents restricted stock units. Each restricted stock unit represents a right to receive one share of Thoratec Corporation common stock upon vesting. The restricted stock units vest in four equal annual installments commencing one year after the grant date.
  2. Annual stock grant according to the Company's 2006 Incentive Stock Plan.
  3. Restricted stock units were granted pursuant to the Company's 2006 Incentive Stock Plan with no payment received for the restricted stock units.
  4. Elisha Finney as Trustee of the Robert D. Finney and Elisha W. Finney 2000 Revocable Trust.
  5. Shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on September 13, 2011, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act 1934, as amended.
  6. This transaction was executed in multiple trades in prices ranging from $31.32 to $31.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.